{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T20:33:52Z","timestamp":1794861232500,"version":"4.9.1"},"reference-count":0,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2003,10,30]],"date-time":"2003-10-30T00:00:00Z","timestamp":1067472000000},"content-version":"vor","delay-in-days":2312,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Immunology"],"published-print":{"date-parts":[[1997,7]]},"abstract":"<jats:p>Chemokines secreted by endothelium have been demonstrated to promote leucocyte recruitment to sites of inflammation. In the present study we investigated the effect of the T lymphocyte\u2010secreted cytokine interleukin (IL)\u201013 on endothelial expression of chemokines. Employing <jats:italic>in situ<\/jats:italic> hybridization and enzyme\u2010linked immunosorbent assay (ELISA) techniques we demonstrate that IL\u201013, which shares many of its activities with IL\u20104, selectively induces expression of the C\u2010C chemokine monocyte chemoattractant protein (MCP)\u20101 in human umbilical vein endothelial cells (HUVEC). However, it fails to up\u2010regulate other C\u2010C and C\u2010X\u2010C chemokines potentially inducible in endothelium such as RANTES (<jats:italic>r<\/jats:italic>egulated on <jats:italic>a<\/jats:italic>ctivation, <jats:italic>n<\/jats:italic>ormal <jats:italic>T<\/jats:italic><jats:italic>e<\/jats:italic>xpressed and <jats:italic>s<\/jats:italic>ecreted), gro\u2010<jats:italic>\u03b1<\/jats:italic>, or IL\u20108. IL\u201013 dose\u2010dependently induces monocyte chemotactic activity by HUVEC which can be efficiently blocked by neutralizing antisera against MCP\u20101. In contrast to the synergistic effect of IL\u201013 and tumour necrosis factor\u2010<jats:italic>\u03b1<\/jats:italic> (TNF\u2010<jats:italic>\u03b1<\/jats:italic>) on endothelial vascular cell adhesion molecule\u20101 (VCAM\u20101) surface expression, TNF\u2010<jats:italic>\u03b1<\/jats:italic>\u2010induced secretion of MCP\u20101 is not augmented by IL\u201013. Studying the signalling pathway activated by IL\u201013 it is demonstrated that a neutralizing monoclonal antibody (mAb) to the 140\u2003000\u2003MW component of the IL\u20104 receptor (IL\u20104R<jats:italic>\u03b1<\/jats:italic>) inhibits the effect of IL\u201013. Immunoprecipitation studies reveal that endothelial IL\u20104R<jats:italic>\u03b1<\/jats:italic> is rapidly tyrosine phosphorylated upon treatment with IL\u201013 and IL\u20104. We furthermore show that both cytokines activate the signal transducer and activator of transcription (Stat) protein\u20106 in endothelial cells. Our data suggest that IL\u201013 partly utilizes components of the IL\u20104 receptor signalling pathway for induction of endothelial MCP\u20101 expression to facilitate recruitment of blood leucocytes.<\/jats:p>","DOI":"10.1046\/j.1365-2567.1997.00263.x","type":"journal-article","created":{"date-parts":[[2003,11,2]],"date-time":"2003-11-02T15:44:35Z","timestamp":1067787875000},"page":"450-457","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Interleukin\u201013 selectively induces monocyte chemoattractant protein\u20101 synthesis and secretion by human endothelial cells. Involvement of IL\u20104R<i>\u03b1<\/i> and Stat6 phosphorylation"],"prefix":"10.1111","volume":"91","author":[{"given":"M.","family":"GOEBELER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"SCHNARR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"TOKSOY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"KUNZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.\u2010B.","family":"BR\u00d6CKER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"DUSCHL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"GILLITZER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,10,30]]},"container-title":["Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2567.1997.00263.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2567.1997.00263.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2567.1997.00263.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T08:47:37Z","timestamp":1694422057000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2567.1997.00263.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,7]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1997,7]]}},"alternative-id":["10.1046\/j.1365-2567.1997.00263.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2567.1997.00263.x","archive":["Portico"],"relation":{},"ISSN":["0019-2805","1365-2567"],"issn-type":[{"value":"0019-2805","type":"print"},{"value":"1365-2567","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,7]]},"assertion":[{"value":"2003-10-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}